Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Study of Temozolomide to Treat Newly Diagnosed Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
- Status
- COMPLETED
- Phase
- PHASE3
Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
- Status
- COMPLETED
- Phase
- N/A
A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status
- Status
- COMPLETED
- Phase
- PHASE3
Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)
- Status
- COMPLETED
- Phase
- PHASE2
Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
- Status
- COMPLETED
- Phase
- PHASE4
Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma
- Status
- UNKNOWN
- Phase
- PHASE2
Dose-Intense Temozolomide in Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)
- Status
- TERMINATED
- Phase
- PHASE2